Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $3.85 million. The enterprise value is $32.17 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, before market open.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 2.17 million shares outstanding. The number of shares has increased by 26.38% in one year.
Current Share Class | 2.17M |
Shares Outstanding | 2.17M |
Shares Change (YoY) | +26.38% |
Shares Change (QoQ) | +61.94% |
Owned by Insiders (%) | 2.39% |
Owned by Institutions (%) | 2.15% |
Float | 1.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.23 |
Forward PS | 0.24 |
PB Ratio | 0.49 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.72 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 4.44.
Current Ratio | 0.95 |
Quick Ratio | 0.12 |
Debt / Equity | 4.44 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -319.25% and return on invested capital (ROIC) is -45.30%.
Return on Equity (ROE) | -319.25% |
Return on Assets (ROA) | -37.42% |
Return on Invested Capital (ROIC) | -45.30% |
Return on Capital Employed (ROCE) | -172.43% |
Revenue Per Employee | $241,020 |
Profits Per Employee | -$829,490 |
Employee Count | 49 |
Asset Turnover | 0.22 |
Inventory Turnover | 0.21 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.68% in the last 52 weeks. The beta is 0.60, so Jaguar Health's price volatility has been lower than the market average.
Beta (5Y) | 0.60 |
52-Week Price Change | -93.68% |
50-Day Moving Average | 2.19 |
200-Day Moving Average | 11.47 |
Relative Strength Index (RSI) | 39.91 |
Average Volume (20 Days) | 147,143 |
Short Selling Information
The latest short interest is 30,894, so 1.42% of the outstanding shares have been sold short.
Short Interest | 30,894 |
Short Previous Month | 44,024 |
Short % of Shares Out | 1.42% |
Short % of Float | 2.03% |
Short Ratio (days to cover) | 0.32 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $11.81 million and -$40.65 million in losses. Loss per share was -$26.56.
Revenue | 11.81M |
Gross Profit | 9.67M |
Operating Income | -32.85M |
Pretax Income | -38.32M |
Net Income | -40.65M |
EBITDA | -30.94M |
EBIT | -32.85M |
Loss Per Share | -$26.56 |
Full Income Statement Balance Sheet
The company has $2.21 million in cash and $30.53 million in debt, giving a net cash position of -$28.32 million or -$13.02 per share.
Cash & Cash Equivalents | 2.21M |
Total Debt | 30.53M |
Net Cash | -28.32M |
Net Cash Per Share | -$13.02 |
Equity (Book Value) | 6.88M |
Book Value Per Share | 3.60 |
Working Capital | -1.32M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -27.68M |
Capital Expenditures | n/a |
Free Cash Flow | -27.68M |
FCF Per Share | -$12.73 |
Full Cash Flow Statement Margins
Gross Margin | 81.88% |
Operating Margin | -278.13% |
Pretax Margin | -350.64% |
Profit Margin | n/a |
EBITDA Margin | -261.96% |
EBIT Margin | -278.13% |
FCF Margin | n/a |
Dividends & Yields
Jaguar Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -26.38% |
Shareholder Yield | -26.38% |
Earnings Yield | -1,055.86% |
FCF Yield | -718.95% |
Analyst Forecast
The average price target for Jaguar Health is $60.00, which is 3,289.83% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $60.00 |
Price Target Difference | 3,289.83% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 1:25.
Last Split Date | Mar 24, 2025 |
Split Type | Reverse |
Split Ratio | 1:25 |
Scores
Jaguar Health has an Altman Z-Score of -12.31 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -12.31 |
Piotroski F-Score | 4 |